Use of heart rate variability (HRV) biofeedback for symptom management among cancer survivors
| العنوان: | Use of heart rate variability (HRV) biofeedback for symptom management among cancer survivors |
|---|---|
| المؤلفون: | John Hanna, William Hendry, Annie Anderson, Regina A. Franco, Mark Allen O'Rourke, Jay P. Ginsberg, James B. Burch, Elizabeth Crowley, Alex Christ, Jameson Sofge, Kerri Susko |
| المصدر: | Journal of Clinical Oncology. 35:10099-10099 |
| بيانات النشر: | American Society of Clinical Oncology (ASCO), 2017. |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | Cancer Research, medicine.medical_specialty, Symptom management, business.industry, medicine.medical_treatment, Cancer, medicine.disease, Biofeedback, stomatognathic system, Oncology, Internal medicine, medicine, Cardiology, Heart rate variability, business, Depression (differential diagnoses), circulatory and respiratory physiology |
| الوصف: | 10099 Background: Late effects of cancer and its treatment include pain, fatigue, stress, and depression all mediated by autonomic dysfunction. Heart Rate Variability (HRV) coherence is an established measure of autonomic dysfunction. Cancer survivors have lower HRV coherence than normal controls. HRV biofeedback (HRV-B) training improves HRV coherence, restores autonomic health, and reduces the above symptoms. This report describes a feasibility study of HRV-B in symptomatic cancer survivors. Methods: In a randomized, waitlist controlled, clinical trial, 179 were screened, 34 enrolled and 31 completed the protocol. Participants in the intervention arm received weekly HRV-B training up to six weeks. Outcome measures assessed at baseline (pre) and after week six (post) included HRV coherence plus Insomnia Symptom Questionnaire (ISQ), Suscro Distress Inventory (SDI), Brief Pain Inventory (BPI), Multi-Dimensional Fatigue Inventory (MFI), Perceived Stress Scale (PSS) and Beck Depression Inventory II (BDI-II). Results: See table below. Conclusions: Delivering HRV Biofeedback training to cancer survivors is feasible at our Cancer Institute. This pilot study provides preliminary evidence that HRV-B for cancer survivors improves HRV coherence and reduces insomnia, pain, fatigue, depression, and stress. The intervention has great potential and further research is indicated. [Table: see text] |
| تدمد: | 1527-7755 0732-183X |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::6bcb3dc036953152bd7a460fbf2a0fcf https://doi.org/10.1200/jco.2017.35.15_suppl.10099 |
| رقم الأكسشن: | edsair.doi...........6bcb3dc036953152bd7a460fbf2a0fcf |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15277755 0732183X |
|---|